Enbrel Supply Interruption Will Be Resolved By June, Immunex Says
Executive Summary
Immunex expects to resolve a temporary interruption in supply for patients registered in the Enbrel Enrollment Program by June
You may also be interested in...
Why Industry Should Model and De-Risk its Pharma Supply Chains
As new biotech drugs come on the market, they will require supply chains that are more agile but less efficient. AstraZeneca’s MedImmune biologics unit looks to boost agility by modeling its supply chains and using a neural network to de-risk them.
Amgen Enbrel Wait List Cleared; Manufacturing “Efficiencies” Boost Supply
Amgen has cleared its waiting list for Enbrel and will allow new patients in the Enbrel Enrollment Program to fill prescriptions for the biologic immediately
Amgen Enbrel Wait List Cleared; Manufacturing “Efficiencies” Boost Supply
Amgen has cleared its waiting list for Enbrel and will allow new patients in the Enbrel Enrollment Program to fill prescriptions for the biologic immediately